{"id":5903,"date":"2026-03-30T15:13:03","date_gmt":"2026-03-30T13:13:03","guid":{"rendered":"https:\/\/heva-data.com\/publication\/prise-en-charge-des-patients-atteints-de-syndromes-myelodysplasiques-a-faible-risque-depuis-2020-en-france-etude-myosotys\/"},"modified":"2026-03-31T10:25:12","modified_gmt":"2026-03-31T08:25:12","slug":"prise-en-charge-des-patients-atteints-de-syndromes-myelodysplasiques-a-faible-risque-depuis-2020-en-france-etude-myosotys","status":"publish","type":"publication","link":"https:\/\/heva-data.com\/en\/publication\/prise-en-charge-des-patients-atteints-de-syndromes-myelodysplasiques-a-faible-risque-depuis-2020-en-france-etude-myosotys\/","title":{"rendered":"Prise en charge des patients atteints de syndromes my\u00e9lodysplasiques \u00e0 faible risque depuis 2020 en France \u2013 \u00e9tude MYOSOTYS"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false},"categories":[5],"class_list":["post-5903","publication","type-publication","status-publish","hentry","category-publication"],"_links":{"self":[{"href":"https:\/\/heva-data.com\/en\/wp-json\/wp\/v2\/publication\/5903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heva-data.com\/en\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/heva-data.com\/en\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/heva-data.com\/en\/wp-json\/wp\/v2\/media?parent=5903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heva-data.com\/en\/wp-json\/wp\/v2\/categories?post=5903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}